Tomasz Brzoska on How Personalized Medicine Benefits SCD Patients
Tomasz Brzoska, Assistant Professor of Medicine in University of Pittsburgh, School of Medicine, shared on LinkedIn:
”Our newest study has just been published.
See how personalized medicine can potentially benefit sickle cell disease patients!
Big thanks to all collaborators and contributors, especially Prithu Sundd, PhD , PhD and Tomasz Kaminski.
Most of the studies were performed at University of Pittsburgh School of Medicine and Vascular Medicine Institute.”
Read the full article here.
Article: CD39 polymorphism enables lung thrombosis in sickle cell disease
Authors: Tomasz Brzoska, Tomasz W. Kaminski, Omika Katoch, Elizaveta V. Menchikova, Adekunle E. Alagbe, Sarah E. Tashbook, Stevan P. Tofovic, Jude C. Jonassaint, Claudette M. St. Croix, Simon C. Watkins, Shane Howe, Joshua J. Field, Amanda A. Seyerle, Tirthadipa Pradhan-Sundd, Cecilia Laurie, Nathan D. Pankratz, Nicholas L. Smith, Ellen L. Goode, James S. Pankow, Charles Kooperberg, Gregory J. Kato, Yingze Zhang, Enrico M. Novelli, Mark T. Gladwin, Edwin K. Jackson, Seyed M. Nouraie, Prithu Sundd
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 17, 2026, 14:30Jecko Thachil Shares a Perspective on von Willebrand Disease
-
Jan 17, 2026, 14:16Fadi Alshrouf Explains Red Blood Cell Exchange
-
Jan 17, 2026, 14:02Abdulrahman Katib on RENOVE’s Support of Practice in VTE Longterm Managment
-
Jan 17, 2026, 13:42David McIntosh Shares a Sequel for Blood and Plasma Donors
-
Jan 17, 2026, 12:36Tomasz Brzoska on The Role of Circulating TF in Pulmonary Arterial Thrombosis
-
Jan 17, 2026, 12:25Ahmed Nasreldein Honored to Moderate Scientific Session at ASO’s Webinar on Stroke Imaging
-
Jan 17, 2026, 12:16Michael Makris on UK’s National Self-Assesment Questionnaire on VTE
-
Jan 17, 2026, 11:58Grigoris Gerotziafas Shares The APICAT Study Post Hoc Analysis
-
Jan 17, 2026, 11:45Emmanuel J Favaloro Shares Yet Another Paper from The 100th Anniversary of VWD